In addition, in the Kaplan‒Meier survival analysis of the TCGA_LIHC data derived from liver cancer patients, alterations in ADAR1 and CTNNB1 were associated with a poorer prognosis than that obtained for patients without these alterations (Fig. 1e). This evidence concerns the gene ADAR and liver cancer.